search
Back to results

Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1

Primary Purpose

Myotonic Dystrophy 1

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Training program
Sponsored by
Université de Sherbrooke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Myotonic Dystrophy 1

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • DM1 diagnosis must be confirmed by genetic analysis;
  • Women sex, aged between 30 and 65 years old;
  • Be able to walk without assistance;
  • Consent of the neurologist must be given to participate in this study;
  • Must reside in the Saguenay-Lac-St-Jean region;
  • Subjects must be able to give their consent freely and voluntarily.

Exclusion Criteria:

  • Patients with any other form of muscular dystrophy are excluded;
  • Any contraindication for strenuous exercise or muscle biopsy.

Sites / Locations

  • Groupe de recherche interdisciplinaire sur les maladies neuromusculaires

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Training program

Arm Description

12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.

Outcomes

Primary Outcome Measures

Changes in maximal isometric muscle strength of the knee extensors
Changes in maximal isometric muscle strength of the knee extensors measure by quantify muscle testing using a handheld dynamometer

Secondary Outcome Measures

Changes in maximal isometric muscle strength of the knee flexors
Changes in maximal isometric muscle strength of the knee flexors measure by quantify muscle testing using a handheld dynamometer
Changes in maximal isometric muscle strength of the hip flexors
Changes in maximal isometric muscle strength of the hip flexors measure by quantify muscle testing using a handheld dynamometer
Changes in maximal isometric muscle strength of the hip extensors
Changes in maximal isometric muscle strength of the hip extensors measure by quantify muscle testing using a handheld dynamometer
Changes in maximal isometric muscle strength of the hip abductors
Changes in maximal isometric muscle strength of the hip abductors measure by quantify muscle testing using a handheld dynamometer
Changes in maximal isometric muscle strength of the ankle dorsiflexors
Changes in maximal isometric muscle strength of the ankle dorsiflexors measure by quantify muscle testing using a handheld dynamometer
Changes in maximal isometric grip strength
Changes in maximal isometric muscle strength of prehension measure by quantify muscle testing using a hand grip dynamometer
Changes in 1-repetition maximum strength of the leg extension exercise
Changes in 1-repetition maximum strength of the leg extension exercise
Changes in 1-repetition maximum strength of the leg press exercise
Changes in 1-repetition maximum strength of the leg press exercise
Changes in 1-repetition maximum strength of the hip abduction exercise
Changes in 1-repetition maximum strength of the hip abduction exercise
Changes in 1-repetition maximum strength of the squat exercise
Changes in 1-repetition maximum strength of the squat exercise
Changes in comfortable walking speed in the 10-meter walk test
Changes in comfortable walking speed in the 10-meter walk test
Changes in maximal walking speed in the 10-meter walk test
Changes in maximal walking speed in the 10-meter walk test
Changes in the number of repetitions in the 30-seconds sit-to-stand test
Changes in the number of repetitions in the 30-seconds sit-to-stand test
Changes in the score of the lower extremity functional scale
Changes in the score of the lower extremity functional scale (LEFS). The LEFS is an 80-point questionnaire with 20 items scored from 0 to 4. A score of 80 means no disfunction while a score of 0 means maximal disfunction.
Changes in the score of the myotonic dystrophy health index
Changes in the score of the myotonic dystrophy health index (MDHI). The MDHI is a 114-item questionnaire scored from 0 to 100, where 0 means no disability and 100 means maximal disability.
Changes in the score of the Fatigue and Daytime Sleepiness Scale
Changes in the score of the Fatigue and Daytime Sleepiness Scale (FDSS). The FDSS is a 12-item questionnaire where all questions are scored from 0 to 2. A higher score means more daytime sleepiness and fatigue.
Changes in the Marin apathy scale
Changes in the Marin apathy scale. The Marin apathy scale is scored by the clinician where he interviews the subject and then scores an 18-item list on a scale of 1 to 4. A high score means more apathy.
Changes in the Hospital Anxiety and Depression Scale
Changes in the Hospital Anxiety and Depression Scale (HADS). The HADS is a 14-item questionnaire with a scale from 0 to 3 for each item. A high score means high depression and anxiety.
Changes in muscle biopsy of the vastus lateralis: muscle fiber typing
Changes in muscle biopsy of the vastus lateralis: muscle fiber typing
Changes in muscle biopsy of the vastus lateralis: muscle fiber size
Changes in muscle biopsy of the vastus lateralis: muscle fiber size (smallest diameter of the fiber)
Changes in muscle biopsy of the vastus lateralis: muscle proteomics
Changes in muscle biopsy of the vastus lateralis: muscle proteomics (protein expression)
Changes in muscle biopsy of the vastus lateralis: muscle transcriptomics
Changes in muscle biopsy of the vastus lateralis: muscle transcriptomics (RNA expression analysis)
Changes in muscle biopsy of the vastus lateralis: mitochondrial function
Changes in muscle biopsy of the vastus lateralis: mitochondrial function. Analysis of mitochondrial markers and enzymes
Changes in muscle biopsy of the vastus lateralis: Nuclear foci
Changes in muscle biopsy of the vastus lateralis: Nuclear foci (changes in accumulation of nuclear foci)
Changes in the time to perform of the Timed Up and Go
Changes in the time to perform of the Timed Up and Go
Changes in the time to perform the Timed stair test
Changes in the time to perform the Timed stair test
Change in the score of the Brief Pain Inventory
Change in the score of the Brief Pain Inventory. The Brief Pain Inventory is a self-administer test that asses the dimensions of pain such as intensity of pain, functional incapacities, social and family repercussions, and psychological distress.
Self-perceived changes in daily life
Self-perceived changes in daily life
Change in the number of falls
Number of falls in the last week and in the last month
Change in score of the DM1-Activ questionnaire
Change in score of the DM1-Activ questionnaire. This questionnaire asses activity and social participation with DM1 population. It contains 20 items with a maximal socre of 40 points, a lower score represent a bigger impact of the disease on activities and social participation.
Change in blood : biochemical markers (CK, Protein C reactive, leukocytes, cytokines, etc.)
Change in blood : biochemical markers (CK, Protein C reactive, leukocytes, cytokines, etc.)
Change in urine sample : exercise biomarkers (-Omics markers)
Change in urine sample : exercise biomarkers (-Omics markers)
Change in saliva sample : exercise biomarkers (-Omics markers)
Change in saliva sample : exercise biomarkers (-Omics markers)
Change of the center of pressure (COP) measure in static posturography : open eyes bipodal position
Change of the center of pressure (COP) in static posturography : open eyes bipodal position
Change of the center of pressure (COP) measure in static posturography : closed eyes bipodal position
Change of the center of pressure (COP) in static posturography : closed eyes bipodal position
Change of the center of pressure (COP) measure in static posturography : open eyes semi-tandem position
Change of the center of pressure (COP) in static posturography : open eyes semi-tandem position
Change of the center of pressure (COP) measure in static posturography : open eyes tandem position
Change of the center of pressure (COP) in static posturography : open eyes tandem position

Full Information

First Posted
May 24, 2022
Last Updated
February 7, 2023
Sponsor
Université de Sherbrooke
Collaborators
Rare Disease Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05400629
Brief Title
Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1
Official Title
Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
January 1, 2022 (Actual)
Primary Completion Date
June 30, 2022 (Actual)
Study Completion Date
January 10, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Sherbrooke
Collaborators
Rare Disease Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myotonic Dystrophy 1

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Participants will complete a 12-week strength training program and return to their normal activities for the following 6 months after the end of the training program.
Masking
None (Open Label)
Masking Description
Most outcomes will not be mask, however the outcome assessor will be mask for all muscle biopsy analysis: while analysing the muscle biopsy outcomes, the outcome assessor will not know if it was from baseline or from after the training program.
Allocation
N/A
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Training program
Arm Type
Experimental
Arm Description
12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.
Intervention Type
Other
Intervention Name(s)
Training program
Intervention Description
12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.
Primary Outcome Measure Information:
Title
Changes in maximal isometric muscle strength of the knee extensors
Description
Changes in maximal isometric muscle strength of the knee extensors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline, week 6, week 12, month 3 and month 6
Secondary Outcome Measure Information:
Title
Changes in maximal isometric muscle strength of the knee flexors
Description
Changes in maximal isometric muscle strength of the knee flexors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline and week 12
Title
Changes in maximal isometric muscle strength of the hip flexors
Description
Changes in maximal isometric muscle strength of the hip flexors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline and week 12
Title
Changes in maximal isometric muscle strength of the hip extensors
Description
Changes in maximal isometric muscle strength of the hip extensors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline and week 12
Title
Changes in maximal isometric muscle strength of the hip abductors
Description
Changes in maximal isometric muscle strength of the hip abductors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline and week 12
Title
Changes in maximal isometric muscle strength of the ankle dorsiflexors
Description
Changes in maximal isometric muscle strength of the ankle dorsiflexors measure by quantify muscle testing using a handheld dynamometer
Time Frame
At baseline and week 12
Title
Changes in maximal isometric grip strength
Description
Changes in maximal isometric muscle strength of prehension measure by quantify muscle testing using a hand grip dynamometer
Time Frame
At baseline and week 12
Title
Changes in 1-repetition maximum strength of the leg extension exercise
Description
Changes in 1-repetition maximum strength of the leg extension exercise
Time Frame
At baseline, week 6 and week 12
Title
Changes in 1-repetition maximum strength of the leg press exercise
Description
Changes in 1-repetition maximum strength of the leg press exercise
Time Frame
At baseline, week 6 and week 12
Title
Changes in 1-repetition maximum strength of the hip abduction exercise
Description
Changes in 1-repetition maximum strength of the hip abduction exercise
Time Frame
At baseline, week 6 and week 12
Title
Changes in 1-repetition maximum strength of the squat exercise
Description
Changes in 1-repetition maximum strength of the squat exercise
Time Frame
At baseline, week 6 and week 12
Title
Changes in comfortable walking speed in the 10-meter walk test
Description
Changes in comfortable walking speed in the 10-meter walk test
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in maximal walking speed in the 10-meter walk test
Description
Changes in maximal walking speed in the 10-meter walk test
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in the number of repetitions in the 30-seconds sit-to-stand test
Description
Changes in the number of repetitions in the 30-seconds sit-to-stand test
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in the score of the lower extremity functional scale
Description
Changes in the score of the lower extremity functional scale (LEFS). The LEFS is an 80-point questionnaire with 20 items scored from 0 to 4. A score of 80 means no disfunction while a score of 0 means maximal disfunction.
Time Frame
At baseline, week 12, month 6 and month 9
Title
Changes in the score of the myotonic dystrophy health index
Description
Changes in the score of the myotonic dystrophy health index (MDHI). The MDHI is a 114-item questionnaire scored from 0 to 100, where 0 means no disability and 100 means maximal disability.
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in the score of the Fatigue and Daytime Sleepiness Scale
Description
Changes in the score of the Fatigue and Daytime Sleepiness Scale (FDSS). The FDSS is a 12-item questionnaire where all questions are scored from 0 to 2. A higher score means more daytime sleepiness and fatigue.
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in the Marin apathy scale
Description
Changes in the Marin apathy scale. The Marin apathy scale is scored by the clinician where he interviews the subject and then scores an 18-item list on a scale of 1 to 4. A high score means more apathy.
Time Frame
At baseline, week 12, month 6 and month 9
Title
Changes in the Hospital Anxiety and Depression Scale
Description
Changes in the Hospital Anxiety and Depression Scale (HADS). The HADS is a 14-item questionnaire with a scale from 0 to 3 for each item. A high score means high depression and anxiety.
Time Frame
At baseline, week 6, week 12 and month 6
Title
Changes in muscle biopsy of the vastus lateralis: muscle fiber typing
Description
Changes in muscle biopsy of the vastus lateralis: muscle fiber typing
Time Frame
At baseline and week 12
Title
Changes in muscle biopsy of the vastus lateralis: muscle fiber size
Description
Changes in muscle biopsy of the vastus lateralis: muscle fiber size (smallest diameter of the fiber)
Time Frame
At baseline and week 12
Title
Changes in muscle biopsy of the vastus lateralis: muscle proteomics
Description
Changes in muscle biopsy of the vastus lateralis: muscle proteomics (protein expression)
Time Frame
At baseline and week 12
Title
Changes in muscle biopsy of the vastus lateralis: muscle transcriptomics
Description
Changes in muscle biopsy of the vastus lateralis: muscle transcriptomics (RNA expression analysis)
Time Frame
At baseline and week 12
Title
Changes in muscle biopsy of the vastus lateralis: mitochondrial function
Description
Changes in muscle biopsy of the vastus lateralis: mitochondrial function. Analysis of mitochondrial markers and enzymes
Time Frame
At baseline and week 12
Title
Changes in muscle biopsy of the vastus lateralis: Nuclear foci
Description
Changes in muscle biopsy of the vastus lateralis: Nuclear foci (changes in accumulation of nuclear foci)
Time Frame
At baseline and week 12
Title
Changes in the time to perform of the Timed Up and Go
Description
Changes in the time to perform of the Timed Up and Go
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Changes in the time to perform the Timed stair test
Description
Changes in the time to perform the Timed stair test
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Change in the score of the Brief Pain Inventory
Description
Change in the score of the Brief Pain Inventory. The Brief Pain Inventory is a self-administer test that asses the dimensions of pain such as intensity of pain, functional incapacities, social and family repercussions, and psychological distress.
Time Frame
At baseline, week 6, week 12, month 6 and month 9
Title
Self-perceived changes in daily life
Description
Self-perceived changes in daily life
Time Frame
At week 12
Title
Change in the number of falls
Description
Number of falls in the last week and in the last month
Time Frame
At baseline, week 12, month 6 ans month 9
Title
Change in score of the DM1-Activ questionnaire
Description
Change in score of the DM1-Activ questionnaire. This questionnaire asses activity and social participation with DM1 population. It contains 20 items with a maximal socre of 40 points, a lower score represent a bigger impact of the disease on activities and social participation.
Time Frame
At baseline, week 6, week 12, month 6 ans month 9
Title
Change in blood : biochemical markers (CK, Protein C reactive, leukocytes, cytokines, etc.)
Description
Change in blood : biochemical markers (CK, Protein C reactive, leukocytes, cytokines, etc.)
Time Frame
At baseline and week 12
Title
Change in urine sample : exercise biomarkers (-Omics markers)
Description
Change in urine sample : exercise biomarkers (-Omics markers)
Time Frame
At baseline and week 12
Title
Change in saliva sample : exercise biomarkers (-Omics markers)
Description
Change in saliva sample : exercise biomarkers (-Omics markers)
Time Frame
At baseline and week 12
Title
Change of the center of pressure (COP) measure in static posturography : open eyes bipodal position
Description
Change of the center of pressure (COP) in static posturography : open eyes bipodal position
Time Frame
At baseline, week 6, week 12, 6 months and 9 months
Title
Change of the center of pressure (COP) measure in static posturography : closed eyes bipodal position
Description
Change of the center of pressure (COP) in static posturography : closed eyes bipodal position
Time Frame
At baseline, week 6, week 12, 6 months and 9 months
Title
Change of the center of pressure (COP) measure in static posturography : open eyes semi-tandem position
Description
Change of the center of pressure (COP) in static posturography : open eyes semi-tandem position
Time Frame
At baseline, week 6, week 12, 6 months and 9 months
Title
Change of the center of pressure (COP) measure in static posturography : open eyes tandem position
Description
Change of the center of pressure (COP) in static posturography : open eyes tandem position
Time Frame
At baseline, week 6, week 12, 6 months and 9 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: DM1 diagnosis must be confirmed by genetic analysis; Women sex, aged between 30 and 65 years old; Be able to walk without assistance; Consent of the neurologist must be given to participate in this study; Must reside in the Saguenay-Lac-St-Jean region; Subjects must be able to give their consent freely and voluntarily. Exclusion Criteria: Patients with any other form of muscular dystrophy are excluded; Any contraindication for strenuous exercise or muscle biopsy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elise Duchesne, Ph.D
Organizational Affiliation
Université du Québec à Chicoutimi
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
City
Saguenay
State/Province
Quebec
ZIP/Postal Code
G7X 7X2
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1

We'll reach out to this number within 24 hrs